Jilin Liyuan Precision Manufacturing Co., Ltd. (002501.SZ): BCG Matrix [Apr-2026 Updated]

Jilin Liyuan's lineup is being reshaped by high-growth Stars-NEV battery trays and lightweight automotive structures-poised to drive valuation while mature Cash Cows in rail transit and electronics fund expansion; critical capital-allocation choices loom for Question Marks in photovoltaic frames and medical parts that need heavy CAPEX to scale, and underperforming Dogs in commodity industrial and construction lines are ripe for exit to free up resources-read on to see how these moves will steer the company's next chapter.

Jilin Liyuan Precision Manufacturing Co., Ltd. (002501.SZ) - BCG Matrix Analysis: Stars

Stars - Rapid expansion in NEV battery trays: The NEV battery tray business is the company's primary 'Star,' contributing 42.0% of total revenue as of Q4 2025 and operating in a market expanding at ~28% CAGR driven by EV adoption across Asia.

The unit's relative market share among independent aluminum processors for Tier 1 battery manufacturers is 12.0% domestically. Gross margins in the segment have stabilized at 18.5% after production optimization at the Shenyang base. Capital expenditure of RMB 350 million between 2024-2025 was directed to doubling automated welding capacity, increasing throughput and lowering unit labor costs.

Key competitive and operational drivers for the NEV battery tray Star:

• Scale and vertical integration: increased automated welding capacity reduces per-unit cost and improves lead times.
• Customer concentration and qualification: qualification with multiple Tier 1 battery makers supports stable order flow.
• Margin resiliency: 18.5% gross margin provides room for continued reinvestment and pricing flexibility.
• Market exposure: high market growth (28% CAGR) sustains revenue ramp potential and valuation multiple expansion.

Stars - Strategic growth in automotive structural parts: Lightweight automotive structural components represent a second Star-class business, accounting for 15.0% of total revenue with a segment growth rate of ~22% annually driven by OEM lightweighting programs.

Liyuan holds an 8.0% share of the specialized high-strength 7000-series aluminum extrusion market for passenger vehicles. Operating margins for this precision-engineered parts segment are approximately 16.0%, materially above traditional industrial extrusion margins. The company achieved a 12.0% ROI on multi-station extrusion press lines commissioned in early 2025. Ongoing R&D investment is 6.0% of segment sales to sustain material and process leadership.

Strategic priorities and executional levers for the structural parts Star:

• Product R&D: 6% of segment sales allocated to alloys, joining processes, and fatigue life testing to maintain technical differentiation.
• Production efficiency: multi-station extrusion press lines delivering 12% ROI and improved throughput to meet OEM cadence.
• Margin management: targeting stable 16% operating margins through mix optimization toward higher-value, complex components.
• Customer diversification: expanding OEM qualification to reduce single-customer exposure while targeting global Tier 1 suppliers.

Segment-level performance summary (combined Stars): In aggregate, the NEV battery tray and lightweight structural parts Stars account for 57.0% of company revenue, operate in markets growing at 22-28% annually, and deliver gross/operating margins in the 16-18.5% range. Recent CAPEX (RMB 350m) and targeted R&D (6% of structural sales) underpin capacity expansion and technology leadership, positioning these units as the primary drivers of future valuation and cash‑generation.

Jilin Liyuan Precision Manufacturing Co., Ltd. (002501.SZ) - BCG Matrix Analysis: Cash Cows

Cash Cows

The rail transit component division operates as a core cash cow for the company, delivering steady revenue and high incremental cash generation from mature assets. The division contributes 25% to annual turnover while operating in a low-growth market (≈4% CAGR). Liyuan's estimated 15% domestic market share in high-speed rail body extrusion supports a 22% operating margin and an ROI >14% on established production lines. Annual capital expenditure requirements are modest (<40 million RMB) because major equipment is fully depreciated, so free cash flow remains high and predictable.

The consumer electronics frames business is a secondary but reliable cash cow. It contributes 10% of total revenue within a market expanding at ~5% annually. Liyuan holds a steady 10% share as a secondary supplier to major global laptop and smartphone OEMs. Long-term supply contracts and high production yields maintain gross margins near 19%, producing stable returns and enabling the company to allocate surplus profits to growth areas. As of December 2025, ROIC for this segment is approximately 12% and reinvestment needs remain low, allowing roughly 60 million RMB of annual profit to be redirected to higher-growth divisions.

Key implications for corporate portfolio management:

• Rail transit cash flows (high margin, low capex) should continue to fund R&D and investment in Stars (high-growth, high-share) without aggressive expansion in the mature rail market.
• Consumer electronics frames provide predictable surplus cash and serve as a buffer for cyclical demand in OEM markets.
• Preserve asset efficiency in both units to maintain >12% ROI and ensure at least ~100 million RMB+ of annual internal funding capacity (rail transit cash generation + ~60 million RMB from electronics), subject to total turnover scale.

Jilin Liyuan Precision Manufacturing Co., Ltd. (002501.SZ) - BCG Matrix Analysis: Question Marks

Question Marks - Emerging growth in photovoltaic aluminum frames: The photovoltaic frame segment is in a high-growth market with an estimated 35% annual expansion driven by accelerating global solar installations and utility-scale projects. Liyuan's current market share in this highly fragmented sector is below 5%, reflecting recent entry into upstream and downstream supply chains. The segment contributes 12% to consolidated revenue, but intense price competition produces thin gross margins of 9%. Planned CAPEX to reach scale and cost leadership is 200 million RMB targeted for 2026. Current segment ROI is approximately 6%, and projected payback periods exceed 5 years at present pricing and utilization assumptions.

Key strategic considerations for photovoltaic frames include whether to commit the 200 million RMB CAPEX to scale production, pursue vertical integration for aluminum processing to improve margins, or pursue partnerships to increase market access while limiting capital outlay.

• Investment options: Full CAPEX (200M RMB), phased CAPEX, or JV/contract manufacturing.
• Operational levers: Improve yields, increase automation, lock in long-term aluminum contracts to stabilize costs.
• Revenue levers: Target utility-scale and rooftop OEMs, secure long-term supply contracts to reduce price volatility.
• Performance targets: Aim to lift market share to 10-15% within 3-5 years and gross margin to 14-16% post-scale.

Question Marks - Potential in high-end medical equipment parts: Medical equipment aluminum components represent a smaller but higher-margin niche, accounting for 5% of total revenue. The medical parts market for high-end diagnostic imaging structural frames is growing at about 18% annually. Liyuan's current share of the addressable high-end imaging frame market is under 2%, constrained by certification, qualification cycles, and customer approval timelines. Gross margins in this niche are attractive at 25%, but scaling requires significant specialized investment. Management faces a decision whether to commit 80 million RMB to specialized testing and certification equipment to accelerate approval and capture more share. Current capacity utilization for this segment is low at 40% as the company pursues client approvals and regulatory qualification.

Strategic levers for the medical segment should focus on targeted investment to meet certification requirements, customer co-development agreements, and capacity planning to improve utilization and shorten time-to-revenue after approval.

• Investment trade-off: 80M RMB vs. slower organic approval without CAPEX.
• Market entry tactics: Pilot projects with OEMs, subcontractor partnerships, third-party certification services.
• Operational focus: Increase quality control, traceability, and documentation to meet ISO and device-specific standards.
• Financial targets: Raise utilization to >75% within 24 months of certification to reach targeted ROI of 18-22%.

Jilin Liyuan Precision Manufacturing Co., Ltd. (002501.SZ) - BCG Matrix Analysis: Dogs

Dogs - Stagnant performance in general industrial profiles: General industrial aluminum profiles now represent only 8% of total revenue (≈ RMB 160 million of RMB 2.0 billion total revenue, FY2025), down from ~25% a decade ago. The segment operates in a saturated, commodity-driven market with an annualized market contraction of -2% as customers transition to specialized alloys and engineered profiles.

Liyuan's relative market share in general industrial profiles has contracted to ~3% of the addressable commodity profile market, reflecting deliberate strategic deprioritization in favor of higher-value product lines. Operating margin for this division has compressed to approximately 4%, which is near the company's weighted average cost of capital and provides minimal surplus for reinvestment. Total asset turnover for the division is 0.6x, indicating low capital efficiency versus corporate average asset turnover of ~1.2x.

Dogs - Legacy construction aluminum materials: The construction aluminum segment now contributes only ~3% of total revenue (≈ RMB 60 million FY2025) and is facing a structural market decline of ~-5% annually due to building sector slowdowns and substitution by advanced materials. Liyuan's market share in construction materials is ~1%, lacking scale vis-à-vis specialized construction suppliers.

Gross margins in the construction aluminum business frequently approach zero or negative figures after accounting for logistics, fabrication variances and raw material price volatility. Capacity utilization has fallen to ~15% as of year-end 2025. Management is actively evaluating a full exit from this segment, which would involve liquidation or disposal of approximately RMB 30 million in underperforming fixed assets (extrusion lines, dies, ancillary equipment).

Operational and strategic implications for Dog-class divisions:

• Maintain only necessary working capital and minimize incremental CapEx for commodity lines (target maintenance CapEx ≤ RMB 10m p.a.).
• Prepare asset disposal plan for construction segment: targeted realization RMB 30m within 12-18 months, net of selling costs.
• Reallocate freed capacity and capital toward high-margin specialty alloys and precision extrusions where company holds stronger positions.
• Consider third-party tolling or contract manufacturing for remaining commodity orders to reduce fixed-cost base and preserve customer relationships.
• Monitor price volatility hedging for residual commodity exposure; set strict margin floors (e.g., no bids below 5% operating margin).